By: Matthew Herper From: forbes.com The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field of genetic research, to which it has until now turned a blind eye. More than 11,000 of these tests, known as laboratory-developed tests, created by 2,000 different laboratories, could be included in the new regulatory …
Trials let more patients get ‘breakthrough’ cancer therapies closer to home
By: Liv Osby From: greenvilleonline.com Rhonda McNeely will never forget that November day she had to tell her children she had advanced cancer. “When you have to come home and tell your daughters that you have cancer,” she said, “the looks in their eyes … it was a very sobering thing for all of us.” If there was any ray …
Amgen colorectal cancer drug gains U.S. approval for wider use
By: By Alex Wayne, Bloomberg News From: chicagotribune.com Amgen Inc. won expanded U.S. approval for its drug Vectibix as an initial treatment in patients with a type of advanced colorectal cancer who first undergo genetic screening. The drug was cleared by the Food and Drug Administration as an initial treatment in conjunction with chemotherapy for patients whose tumors have a …